Noom vs Sequence for Weight Loss: Which GLP-1 Program Is Better?
An independent, side-by-side comparison of Noom and Sequence for GLP-1 weight loss programs — pricing, medications, protocols, and patient experience.

Quick Verdict
Best Price
Noom
Starting at $Infinity/mo vs $Infinity/mo
Most Medications
Noom
2 medications vs 2
Best for Beginners
Sequence
Hybrid, fast onboarding
Head-to-Head Comparison
Pricing Breakdown
Side-by-side pricing for every medication.
| Medication | Noom | Sequence | Savings |
|---|---|---|---|
| Semaglutide | Not offered | Not offered | Only at Sequence |
| Tirzepatide | Not offered | Not offered | Only at Sequence |
Pros and Cons
Noom
- Unique combination of GLP-1 medication with an established CBT-based behavior-change curriculum
- Video consultations required (more thorough clinical evaluation than async providers)
- Over a decade of behavior-change coaching experience predating the medication program
- Personal coach and group coaching included in the price
- Competitive compounded semaglutide pricing ($149/month) for what's included
- Cannot opt out of the coaching/app component to lower cost
- Noom Med is relatively new (launched 2023)
- No published clinical trial data specifically for the combined Med + coaching program
- No lab testing included
- Pricing has been volatile
Sequence
- Founded by obesity medicine specialists
- Insurance-first approach can save patients hundreds per month on brand-name GLP-1 medications
- Video consultations with experienced clinicians, not just questionnaire-based async reviews
- Prior authorization and insurance appeals support included in membership
- Personalized titration managed through follow-up video visits
- Higher total cost for cash-pay patients
- The $99/month membership is charged on top of medication costs (unlike all-inclusive platforms)
- No published independent outcomes data for their patient population
- Insurance navigation success varies
- Less established brand than Hims or Ro
How They Compare
Our editorial assessment across key dimensions.
In-Depth Comparison
By maria-torres · Last updated March 27, 2026
Noom vs Sequence for Weight Loss: Which GLP-1 Program Is Better?
Noom and Sequence both combine GLP-1 medications with clinical support — but their philosophies are fundamentally different. Noom leads with behavioral psychology and adds medication on top. Sequence leads with clinical rigor and medication expertise. Understanding this distinction is key to choosing the right one.
How do Noom and Sequence compare on price?
Noom is cheaper on paper for compounded semaglutide ($149/mo all-in vs. $298+/mo with Sequence's membership). But Sequence's insurance-first model means patients with GLP-1 coverage could pay as little as $99/mo + a copay — potentially less than Noom's cash-pay price.
| Noom | Sequence | |
|---|---|---|
| Membership/program fee | Bundled into medication cost | $99/mo |
| Compounded semaglutide | $149/mo (all-in) | $199-$349/mo + $99/mo membership |
| Compounded tirzepatide | Not available | $349/mo + $99/mo membership |
| Brand Wegovy | $299-$499/mo | Insurance copay + $99/mo |
| Brand Zepbound | $299-$499/mo | Insurance copay + $99/mo |
| Video consultations | Included | Included |
Clinical Approach
Noom's Model: Psychology First
Noom started as a weight loss app built on cognitive behavioral therapy (CBT) principles, then added GLP-1 prescribing. The core program includes:
- CBT-based curriculum: 10-15 minute daily lessons covering food psychology, emotional eating, and habit formation
- Personal coaching: Assigned coach with regular check-ins
- Group sessions: Peer support through coached group interactions
- Video consultations: Required for medication prescribing
- Medication: Positioned as one tool alongside behavioral change
Noom's bet is that medication alone leads to weight regain — behavioral change is what makes results last.
Sequence's Model: Clinical Rigor First
Sequence was built specifically around obesity medicine. The focus is on getting the right medication, at the right dose, with expert clinical oversight:
- Board-certified specialists: Obesity medicine physicians and endocrinologists
- Insurance navigation: Active prior authorization support — their core competency
- Personalized titration: Dose adjustments through follow-up video visits (typically monthly)
- Lab work: Recommended (not included, but actively coordinated)
- Primary care coordination: Can work alongside your existing doctor
Sequence's bet is that expert medication management with proper titration produces the best outcomes.
What medications do Noom and Sequence offer?
Sequence offers a broader medication menu, including compounded tirzepatide and Saxenda — an older GLP-1 that may be preferred in certain clinical scenarios or for patients who haven't responded to semaglutide.
| Medication | Noom | Sequence |
|---|---|---|
| Compounded semaglutide | ✅ | ✅ |
| Compounded tirzepatide | ❌ | ✅ |
| Brand Wegovy | ✅ | ✅ |
| Brand Zepbound | ✅ | ✅ |
| Brand Saxenda (liraglutide) | ❌ | ✅ |
What's Included
| Feature | Noom | Sequence |
|---|---|---|
| Video consultations | ✅ (required) | ✅ (standard, monthly) |
| Board-certified obesity specialists | Varies | ✅ |
| CBT-based curriculum | ✅ | ❌ |
| Personal coaching | ✅ | ❌ |
| Group support | ✅ | ❌ |
| Insurance navigation | ❌ | ✅ |
| Prior authorization support | ❌ | ✅ |
| Personalized titration schedule | Standard | ✅ |
| Lab work | Not included | Recommended/coordinated |
| Primary care coordination | ❌ | ✅ |
The difference is clear: Noom gives you a structured behavioral program with medication. Sequence gives you expert medication management with insurance support.
Program Experience
What a Month on Noom Looks Like
- Daily 10-15 minute app-based lessons on food psychology and habits
- Regular coach check-ins and group sessions
- Food logging and tracking
- Video consultation with a clinician for medication
- Medication shipped to your door
Patient feedback is mixed on the curriculum — some find it transformative, others report the content becomes repetitive after the first few months. Coaching quality varies. The app can also feel aggressive about engagement and upselling.
What a Month on Sequence Looks Like
- Monthly video visit with your obesity medicine specialist
- Medication adjustments based on progress and side effects
- Insurance prior authorization handled by their team
- Prescription sent directly (pharmacy or shipped)
- Coordination with your primary care physician if needed
Sequence's experience is more traditional clinical care — you see a specialist, they manage your medication, and the insurance team does the paperwork. There's no behavioral curriculum or daily engagement requirement.
What are the pros and cons of Noom vs Sequence?
Noom
Pros:
- CBT-based curriculum addresses psychological drivers of eating
- Lower entry price for compounded semaglutide ($149/mo)
- Personal coaching and group support included
- Massive user base (50+ million downloads)
- Video consultations included
Cons:
- Curriculum becomes repetitive for many patients
- Coaching quality is inconsistent
- Aggressive upselling and retention practices reported
- No lab testing
- No insurance navigation
- No compounded tirzepatide
Sequence
Pros:
- Board-certified obesity medicine specialists
- Insurance-first model can dramatically reduce costs
- Prior authorization expertise (their core strength)
- Compounded tirzepatide available
- Monthly video consultations standard
- Can coordinate with your primary care physician
Cons:
- Higher base cost ($99/mo membership + medication)
- No behavioral coaching or curriculum
- Slower onboarding (1-3 weeks for prior authorization)
- Smaller, newer company
- No structured support program beyond clinical visits
Which should you choose: Noom or Sequence?
When patients ask "Noom vs Sequence which is better," the honest answer is that they're targeting different needs entirely. Patients who have insurance may find Sequence worth it despite the higher upfront cost. Patients who want behavioral support alongside their medication will find more value in Noom.
Choose Noom if:
- You want behavioral support alongside medication — The CBT curriculum and coaching can help build lasting habits
- Budget is the priority for cash-pay patients — $149/mo all-in is hard to beat
- You benefit from structured daily engagement — The app-based lessons provide accountability
- You're new to weight management and want education alongside treatment
Choose Sequence if:
- You have insurance that may cover GLP-1s — Sequence's prior authorization expertise is their biggest differentiator
- Clinical expertise is the priority — Board-certified obesity medicine specialists with personalized titration
- You want compounded tirzepatide — Available at Sequence, not at Noom
- You prefer a clinical relationship over an app experience — Monthly video visits with a specialist
- You already have good health habits and primarily need expert medication management
Summary Table
| Factor | Noom | Sequence |
|---|---|---|
| Monthly cost (compounded semaglutide) | $149 | $298+ ($99 + medication) |
| CBT curriculum | ✅ | ❌ |
| Personal coaching | ✅ | ❌ |
| Board-certified obesity specialists | Varies | ✅ |
| Insurance navigation | ❌ | ✅ |
| Compounded tirzepatide | ❌ | ✅ |
| Video consultations | ✅ | ✅ (monthly) |
| Our rating | 3.5/5 | 4.2/5 |
Noom and Sequence serve fundamentally different needs. Noom is for patients who want a structured behavioral program wrapped around medication — the curriculum and coaching are the core value proposition. Sequence is for patients who want expert clinical management and insurance optimization — the specialist care and prior authorization support are what set it apart. If you have insurance, Sequence's model could save you significant money despite the higher membership fee. If you're paying cash and want coaching, Noom delivers more for less.
Frequently Asked Questions
Is Noom or Sequence cheaper for semaglutide? Noom at $149/mo all-in is cheaper for cash-pay patients. But Sequence's insurance navigation can bring your actual cost below that if your plan covers GLP-1s — some patients pay only $99/mo membership + a low copay for branded Wegovy or Zepbound.
Is Sequence worth the $99/mo membership fee? Yes, if you have insurance that may cover GLP-1s. Sequence's prior authorization support has helped many patients access brand Wegovy or Zepbound with only a copay — which often comes out cheaper than Noom's $149/mo cash-pay price for compounded semaglutide.
Does Noom offer tirzepatide? No. Noom does not offer compounded or branded tirzepatide. For tirzepatide access, Sequence is the option between these two.
What is the cheapest way to get semaglutide through Noom? Noom's compounded semaglutide program is $149/mo all-in — that's their base cash-pay price and includes consultation and medication. No separate membership fee.
Can I switch from Noom to Sequence? Yes. There's no long-term contract obligation with either platform. If you start on Noom and later want insurance-navigated access to branded medications or a more clinical approach, switching to Sequence is straightforward.
Does Noom use real doctors for GLP-1 prescriptions? Yes. Noom requires video consultations with licensed healthcare providers for GLP-1 prescriptions. The behavioral curriculum is delivered through the app and coaches, but the prescription pathway involves actual clinicians.
Related Resources
- Noom Weight Loss Review — Full Noom analysis
- Sequence Weight Loss Review — Full Sequence analysis
- Best GLP-1 Weight Loss Programs 2026 — All providers ranked
- GLP-1 Results Timeline FAQ — What to expect and when
- GLP-1 Nausea Management Guide — Managing common side effects
Related Guides
Best Telehealth Providers for Tirzepatide 2026: Ranked by Price and Care
The best telehealth providers for tirzepatide in 2026, ranked by price, protocol, and care quality. From $278/month compounded to brand Zepbound via insurance. No provider paid for placement.
Read guide →Is Compounded Semaglutide Legal and Safe in 2026?
Is compounded semaglutide still legal? We break down the current FDA rules, 30 new warning letters, SAFE Drugs Act, Hims exiting compounded, and what this means for your prescription.
Read guide →Compounded Tirzepatide 2026: What's Happening and What Patients Should Do
Compounded tirzepatide is under active FDA enforcement as of April 2026 — supply is declining but not yet at zero. The 503B enforcement discretion ended over a year ago (March 2025); the FDA has now issued 50+ warning letters including a 30-letter batch in April 2026. Here's what patients need to know and what to do.
Read guide →